Which numbing agent wins for a more comfortable throat scope?

NCT ID NCT07691346

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial compares two common throat-numbing medicines—dyclonine hydrochloride mucilage and tetracaine hydrochloride jelly—to see which one works better for reducing discomfort during an unsedated gastroscopy. About 208 adults scheduled for the procedure will receive one of the two numbing agents before the scope is inserted. The study measures pain, taste, nausea, and how well the medicine clears foam to help doctors choose the best option for patient comfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Dyclonine hydrochloride mucilage and tetracaine hydrochloride jelly
What this could lead to
If one numbing agent proves better, it could become the standard choice for throat anesthesia during gastroscopy, making the procedure more comfortable for patients.
What could go wrong
This is a single-center trial with 208 participants, so results may not apply to all patients. The study compares two existing drugs, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Gastroenterology,General Hospital of Northern Theater Command

    Shenyang, Liaoning, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.